Collection of nasal samples from healthy volunteers
Establishment of a Biobank of Nasal Epithelium Samples From Healthy Volunteers
This study is collecting nasal samples from healthy adults to help researchers learn more about respiratory diseases and develop new treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Hamilton, Montana) |
| Trial ID | NCT06120244 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect nasal epithelium samples from healthy volunteers to establish a biobank for future research on respiratory diseases. Participants aged 18 and older will provide samples during a single visit, where they will also answer questions about their health. The collected samples will be used to study the pathogenesis of emerging respiratory viruses and to develop upper respiratory tract organoids. Individuals with recent respiratory symptoms will be excluded to ensure the health of the samples.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 18 years and older who can provide informed consent.
Not a fit: Patients with a recent history of respiratory symptoms or those who are not healthy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of respiratory viruses and lead to improved prevention and treatment strategies.
How similar studies have performed: While this approach is focused on sample collection, similar studies have successfully established biobanks for respiratory research, indicating potential for valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Aged \>=18 years. * Able to provide informed consent. * Willing to allow biological samples and data to be stored for future research. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * History of respiratory symptoms including but not limited to runny nose, coughing, congestion, and/or fever within the past 14 days. * NIH and laboratory staff with direct involvement in the operation or maintenance of the repository are excluded from participation. * An individual who has any condition that, in the judgment of the investigator, may put them at undue risk or make them unsuitable for participation in the study will be excluded.
Where this trial is running
Hamilton, Montana
- Rocky Mountain Laboratories — Hamilton, Montana, United States (Recruiting)
Study contacts
- Principal investigator: Emmie de Wit, Ph.D. — National Institute of Allergy and Infectious Diseases (NIAID)
- Study coordinator: Emmie de Wit, Ph.D.
- Email: emmie.dewit@nih.gov
- Phone: (406) 375-7490
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.